Management of medication noncompliance in solid-organ transplant recipients

BioDrugs

Volumn 13, Issue 5, 2000, Pages 313-326

  Kaul, Vivek ^a   Khurana, Sandhya ^b   Munoz, Santiago J ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; TACROLIMUS;

CLINICAL PROTOCOL; COMORBIDITY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG COST; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EVALUATION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERPERSONAL COMMUNICATION; ORGAN TRANSPLANTATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; SOCIAL ASPECT; SOCIAL SUPPORT;

EID: 0034122377     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200013050-00002     Document Type: Review

References (89)

1. 1. Hathaway D, Combs C, De Geest S, et al. Patient compliance in transplantation: a report on the perceptions of transplant clinicians. Transplant Proc 1999; 31 (4A Suppl.): 10S-3S
2. 2. Cramer J. Practical issues in medication compliance. Transplant Proc 1999; 31 (4A Suppl.): 7S-9S
3. 3. Gaston R, Hudson S, Ward M, et al. Non compliance masquerading as chronic rejection. Transplant Proc 1999; 31 (4A Suppl.): 21S-6S
4. 4. De Lone P, Trollinger JH, Fox N, et al. Non-compliance in renal transplant recipients: methods for recognition and intervention. Transplant Proc 1989; 21 (6): 3982-4
5. 5. Stanhope M, Lancaster J. Community Health Nursing. St. Louis (MO): CV Mosby, 1984
6. 6. Didlake RH, Dreyfus K, Kerman RM, et al. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988; 20 (3 Suppl.): 63-9
7. 7. Myers KE, Thomson PD, Weiland H. Noncompliance in children and adolescents after renal transplantation. Transplantation 1996; 62 (2): 186-9
8. 8. Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 1998; 66 (12): 1718-26
9. 9. Pullar T, Kumar S, Tindall H, et al. Time to stop counting the tablets? Clin Pharmacol Ther 1989; 46 (2): 163-8
10. 10. Hillbrands LB, Hoitsma AJ, Koene RAP. Medication compliance after renal transplantation. Transplantation 1995; 60 (9): 914-20
11. 11. De Geest S, Vanhaecke J. Methodological issues in transplant compliance research. Transplantation Proc 1999; 31 (4A Suppl.): 81S-3S
12. 12. Papajcik D, Mastroianni B, Goormastic M, et al. A tool to identify risk factors for noncompliance in the adult renal transplant recipient. Transplant Proc 1999; 31 (4A Suppl.): 84S-6S
13. 13. Mozaffari E, Satake J, Woo A, et al. Patient compliance with cyclosporine regimen post solid organ transplantation. Transplant Proc 1999; 31 (4A Suppl.): 87S-88S
14. 14. Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 1989; 64: 169-76
15. 15. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59 (3): 340-7
16. 16. Feinstein AR. On white coat effects and the electronic measurement of compliance. Arch Intern Med 1990; 22: 1110
17. 17. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273
18. 18. De Geest S, Abraham I, Moons P, et al. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant 1998; 17: 854-63
19. 19. Cramer JA, Mattson RH. Monitoring compliance with antiepileptic drug therapy. In: Cramer JA, Spilker B, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991: 123
20. 20. Bromberg JS, Baliga PR. Renal transplantation in a noncompliant patient. N Engl J Med 1994; 330: 371
21. 21. Sketris L, Waite N, Grobler K, et al. Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplant Proc 1994; 26: 2538
22. 22. Schweizer RT, Rovelli M, Palmeri D, et al. Noncompliance in organ transplant recipients. Transplantation 1990; 49: 374
23. 23. Majkowski K. United Resource Networks: how compliance issues affect a managed care transplant network. Transplant Proc 1999; 31 (4A Suppl.): 37S-8S
24. 24. Burgess MM. Ethical and economic aspects of noncompliance and overtreatment. Can Med Assoc J 1989; 141: 777-80
25. 25. Dew MA, Roth LH, Thompson ME, et al. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant 1996 Jun 15; 6: 631-45
26. 26. Dunn J, Vathsala A, Golden D, et al. Impact of race on the outcome of renal transplantation under cyclosporine-prednisone. Transplant Proc 1989; 21 (6): 3946-8
27. 27. Troppmann C, Benedetti E, Gruessner RW, et al. Retransplantation after renal allograft loss due to noncompliance. Indications, outcome, and ethical concerns. Transplantation 1995; 59 (4): 467-71
28. 28. Pirsch JD, Armbrust MJ, D'Alessandro AM, et al. Kidney transplantation in blacks at the University of Wisconsin. Transplant Proc 1989; 21 (6): 3926-8
29. 29. Ramos EL, Kasiske BL, Alexander SR, et al. The evaluation of candidates for renal transplantation. The current practice of U.S. transplant centers. Transplantation 1994; 57 (4): 490-7
30. 30. Wilkinson A. In: Danovitch G, editor. Handbook on kidney transplantation. Boston (MA): Little Brown: 1992: 119
31. 31. Milgrom M, Gharagozloo H, Gomez C, et al. Results of renal transplantation in Miami analyzed by race. Transplant Proc 1989; 21 (6): 3934-6
32. 32. Perdue ST, Terasaki PI. Analysis of interracial variation in kidney transplant and patient survival. Transplantation 1982; 34 (2): 75-7
33. 33. Rovelli M, Palmeri D, Vossler E, et al. Noncompliance in organ transplant recipients. Transplant Proc 1989; 21 (1): 833-4
34. 34. Dunn J, Golden D, Van Buren CT, et al. Causes of graft loss beyond two years in the cyclosporine era. Transplantation 1990; 49 (2): 349-53
35. 35. Swanson MA, Palmeri D, Vossler ED, et al. Noncompliance in organ transplant recipients. Pharmacotherapy 1991; 11 (6): 173S-4S
36. 36. Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts: overriding effects of HLA matching and socioeconomic factors. N Engl J Med 1992; 327: 840-5
37. 37. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation 1993; 55: 51
38. 38. Frazier P, Davis-Ali S, Dahl K. Correlates of noncompliance among renal transplant recipients. Clin Transplants 1994; 8: 550
39. 39. Douglas S, Blixen C, Bartucci MR. Relationship between pretransplant noncompliance and post-transplant outcomes in renal transplant recipients. J Transpl Coord 1996; 6 (2): 53-8
40. 40. Siegal BR, Greenstein SM. Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans and Anglo-Americans. Adv Ren Replace Ther 1997; 4: 46
41. 41. Garcia V, Bittar A, Keitel E, et al. Patient noncompliance as a major cause of kidney graft failure. Transplant Proc 1997; 29: 252-4
42. 42. Greenstein SM, Siegal B, and the Compliance Study Group. Post-renal transplant health beliefs and ethnicity. Transplant Proc 1997; 29: 3741-2
43. 43. Mcdonald J. Issues related to race in transplantation. Transplant Proc 1989; 21: 3411
44. 44. Teperman L, Scantlebury V, Tzakis A, et al. Liver transplantation in black recipients: Pittsburgh. Transplant Proc 1989; 21 (6): 3963-5
45. 45. Sommer BG, Sing DE, Henry ML, et al. The influence of recipient race on renal allograft survival: a single institution analysis. Transplant Proc 1989; 21 (6): 3929-30
46. 46. Salvatierra Jr O. Demographic and transplantation trends among minority groups. Transplant Proc 1989; 21 (6): 3916-7
47. 47. Levenson JL, Olbrisch ME. Psychiatric aspects of heart transplantation. Psychosomatics 1993; 34 (2): 114-23
48. 48. Surman OS. Psychiatric aspects of liver transplantation. Psychosomatics 1994; 35 (3): 297-307
49. 49. Lee C. Cultural dynamics: their importance in multicultral counseling. In: Lee C, Richardson B, editors. Multicultral issues in counseling: new approaches to diversity. Alexandria: American Association for Counseling and Development, 1991
50. 50. Ivey A, Ivey M, Simek-Morgan L. Counseling and psychotherapy: a multicultural perspective. 3rd ed. Boston: Allan & Bacon, 1993
51. 51. Carter R. Cultural values: a review of empirical research and implications for counseling. J Counsel Dev 1991; 70: 164
52. 52. Wood Washington A. Cross-cultural issues in transplant compliance. Transplant Proc 1999; 31 (4A Suppl.): 27S-8S
53. 53. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881-4
54. 54. Rovelli M, Palmeri D, Vossler E, et al. Noncompliance in renal transplant recipients: evaluation by socioeconomic groups. Transplant Proc 1989; 21 (6): 3979-81
55. 55. Santiago Delpin EA, Gonzalez Z, Morales-Otero LA, et al. Transplantation in Hispanics: the Puerto Rico experience. Transplant Proc 1989; 21 (6): 3958-60
56. 56. Rodriguez A, Diaz M, Colon A, et al. Psychosocial profile of noncompliant transplant patients. Transplant Proc 1991; 23 (2): 1807-9
57. 57. Kern DE, Cole KA. Patient education, behavior change and compliance. In: Barker LR, Burton JR, Zieve PD, et al., editors. Principles of ambulatory medicine. 5th ed. Baltimore (MD): Williams & Wilkins, 1999: 41-61
58. 58. Pedersen P. Ten frequent assumptions of cultural bias in counseling. J Multicult Counsel Dev 1987; 15: 16
59. 59. Leventhal H, Zimmerman R, Gutman M, et al. In: Gentry WD, editors. Handbook of behavioral medicine. New York: The Guilford Press, 1984
60. 60. Orem DE. Nursing. Concept of practice. 4th ed. St Louis (MO): Mosby Year Book, 1991: 145
61. 61. Evers GCM. Appraisal of self care agency ASA scale. Maastricht: Van Goreum, 1989
62. 62. Campbell B, Etringer G. Posttransplant quality of life issues: depression-related noncompliance in cardiac transplant patients. Transplant Proc 1999; 31 (4A Suppl.) 595-605
63. 63. Raiz L, Kilty K, Henry M, et al. Medication compliance following renal transplantation. Transplantation 1999: 68 (1): 51-5
64. 64. Kory L. Nonadherence to immunosuppressive medications: a pilot survey of members of the transplant recipients international organization. Transplant Proc 1999; 31 (4A Suppl.): 14S-5S
65. 65. Bandura A. Self-efficacy theory: toward a unifying theory of behavior change. Psychol Rev 1977; 84: 191
66. 66. Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q 1984; 11 (1): 1
67. 67. Wallston KA, Wallston BS, DeVillis R. Development of the multidimensional health locus of control scales. Health Educ Monogr 1978; 6: 160
68. 68. Cramer JA. Identifying and improving compliance patterns: a composite plan for health care providers. In: Cramer JA. Spilker B, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991: 387
69. 69. Svarstad BL. Physician-patient communication and patient conformity with medical advice. In: Mechanic D. editors. The growth of bureaucratic medicine. New York: Wiley. 1976; 243
70. 70. Siegal B, Greenstein SM. Differences between compilers and partial compilers: a multicenter study. Transplant Proc 1998; 30: 1310-1
71. 71. Prieto LR, Miller DS, Gayowski T, et al. Multicultural issues in organ transplantation: the influence of patient's cultural perspectives on compliance with treatment. Clin Transplant 1997; 11 (6): 529-35
72. 72. Freeman AM, Sokol RS, Folks PG, et al Psychiatric characteristics of patients undergoing cardiac transplantation. Psychiatr Med 1988; 6 (2): 8-23
73. 73. Freeman AM, Folks DG, Sokol RS, et al. Cardiac transplantation: clinical correlates of psychiatric outcome. Psychosomatics 1988; 29 (1): 47
74. 74. Sue D, Sue DW. Counseling the culturally different theory and practice. New York: Wiley and Sons, 1990
75. 75. Sodowsky G, Wai Ming Lai E, Plake D. Moderating effects of sociocultural variables on acculturation attitudes of Hispanics and Asian-Americans. J Counsel Dev 1991; 70: 194
76. 76. D'Andrea M, Daniels J, Heck R. Evaluating the impact of multicultural counseling training. J Counsel Dev; 70: 143
77. 77. Settle MA. Increased compliance through targeted behavioral interventions. Transplant Proc 1999; 31 (4A Suppl.): 45S
78. 78. Thomas C. The Arizona experience: empowering patients and families. Transplant Proc 1999; 31 (4A Suppl.): 76S-7S
79. 79. Faulk JS. Peer-to-peer transplant mentor program: the San Diego experience. Transplant Proc 1999; 31 (4A Suppl.): 75S
80. 80. Girvan C, Wong K. An individualized teaching and self-medication program to promote compliance in newly transplanted pediatric patients. Transplant Proc 1999; 31 (4A Suppl.): 73S-4S
81. 81. Morrow D, Leirer V, Sheikh J. Adherence and medication instructions: review and recommendations. J Am Geriatr Soc 1988; 36: 1147
82. 82. Raynor DK, Booth TG, Blenkinsopp A. Effects of computer generated reminder charts on patients' compliance with drug regimens. BMJ 1993; 306: 1158
83. 83. Ley P. Memory for medical information. Br J Soc Clin Psychol 1979; 18: 245
84. 84. Rossi SJ, McEnroe DL, Tanner T, et al. Liquid medication dispensing and dose monitoring: the cyclotech cyclosporine oral solution dispenser. Transplant Proc 1999; 31 (4A Suppl.): 65S-6S
85. 85. Ratcliffe PJ, Dudley CRK, Higgins RM, et al. Randomized control trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996; 384: 643-8
86. 86. Stegall MD, Everson GT, Schroter G, et al. Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension and hypercholesterolemia without causing graft loss. Hepatology 1997; 25: 173-7
87. 87. Padbury RTA, Gunson BK, Dousset B, et al. Steroid withdrawal from long-term immunosuppression in liver allograft recipients. Transplantation 1993; 55: 789-94
88. 88. Mazariegos GV, Reyes J, Marino IR, et al. Weaning of immunosuppresion in liver transplant recipients. Transplantation 1997; 63: 243-9
89. 89. Orosz CG. Transplantation without immunosuppression: what the future may hold. Cleve Clin J Med 1999; 66 (7): 395-6